As President of Global Vaccines, Drew leads the MSD vaccines commercial enterprise to enable access to products across the company’s portfolio, spanning HPV, pneumococcal, pediatric, Ebola and pipeline assets. A career pharmaceutical professional and executive leader, Drew has more than 20 years’ experience in vaccines across diverse geographies including emerging markets. Drew joined Merck in 2019 as Vice President of Marketing and Global Commercial Lead for the company’s pneumococcal vaccines portfolio. Prior to that role, Drew held several positions at Pfizer from 2007 to 2019, including Vice President & General Manager of the Vaccine Business Unit in Japan and Regional Marketing and Launch Lead for PREVNAR 13® for Europe and Asia, based in Paris, France. Prior to joining Pfizer, Drew served in pharmaceutical industry roles across sales, marketing, management consulting and medical affairs. Having lived and worked across 4 continents, Drew understands the complexity of unmet medical needs and access challenges in both developed and emerging markets and brings a lifelong passion to contribute to global health and health equity. Since 2023, Drew has served as the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) industry representative to the GAVI board. Drew holds a Master of Business Administration and Doctor of Pharmacy (Healthcare Marketing and Pharmacy joint degree) from Drake University in Des Moines, Iowa.